Full text
PDF![1270](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/4da90b7fec21/brmedj02497-0048.png)
![1271](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/b8f342c0a960/brmedj02497-0049.png)
![1272](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/8500661b691a/brmedj02497-0050.png)
![1273](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/6f5aa81602fb/brmedj02497-0051.png)
![1274](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/86d98e042977/brmedj02497-0052.png)
![1275](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/5667/2123327/5cbdc7deb153/brmedj02497-0053.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- ASHENBRUCKER H., CARTWRIGHT G. E., GOLDBERG A., WINTROBE M. M. Studies on the biosynthesis of heme in vitro by avian erythrocytes. Blood. 1956 Sep;11(9):821–833. [PubMed] [Google Scholar]
- CHISOLM J. J., Jr, HARRISON H. E. Quantitative urinary coproporphyrin excretion and its relation to edathamil calcium disodium administration in children with acute lead intoxication. J Clin Invest. 1956 Oct;35(10):1131–1138. doi: 10.1172/JCI103367. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DUDLEY H. R., RITCHIE A. C., SCHILLING A., BAKER W. H. Pathologic changes associated with the use of sodium ethylene diamine tetra-acetate in the treatment of hypercalcemia; report of two cases with autopsy findings. N Engl J Med. 1955 Mar 3;252(9):331–337. doi: 10.1056/NEJM195503032520901. [DOI] [PubMed] [Google Scholar]
- FOREMAN H., FINNEGAN C., LUSHBAUGH C. C. Nephrotoxic hazard from uncontrolled edathamil calcium-disodium therapy. J Am Med Assoc. 1956 Mar 24;160(12):1042–1046. doi: 10.1001/jama.1956.02960470038010. [DOI] [PubMed] [Google Scholar]
- MAUZERALL D., GRANICK S. The occurrence and determination of delta-amino-levulinic acid and porphobilinogen in urine. J Biol Chem. 1956 Mar;219(1):435–446. [PubMed] [Google Scholar]
- OHLSSON W. T. Penicillamine as lead-chelating substance in man. Br Med J. 1962 May 26;1(5290):1454–1456. doi: 10.1136/bmj.1.5290.1454. [DOI] [PMC free article] [PubMed] [Google Scholar]
- PETERS H. A., WOODS S., EICHMAN P. L., REESE H. H. The treatment of acute porphyria with chelating agents: a report of 21 cases. Ann Intern Med. 1957 Nov;47(5):889–899. doi: 10.7326/0003-4819-47-5-889. [DOI] [PubMed] [Google Scholar]
- SEIGNETTE W. T., HAANEN C. A., JANSEN A. P., MAJOOR C. L. [The effects of penicillamine and versenate in the treatment of Wilson's disease and lead poisoning]. Folia Med Neerl. 1959 Jun;2:65–78. [PubMed] [Google Scholar]
- WALSHE J. M. Penicillamine, a new oral therapy for Wilson's disease. Am J Med. 1956 Oct;21(4):487–495. doi: 10.1016/0002-9343(56)90066-3. [DOI] [PubMed] [Google Scholar]